Novel GIPR Antagonists for Treating Obesity and Type 2 Diabetes Mellitus

被引:0
|
作者
Sabnis, Ram W. [1 ]
机构
[1] Smith Gambrell & Russell LLP, Atlanta, GA 30309 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2024年 / 15卷 / 12期
关键词
D O I
10.1021/acsmedchemlett.4c00535
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Provided herein are novel GIPR antagonists, pharmaceutical compositions, use of such compounds in treating obesity and type 2 diabetes mellitus and processes for preparing such compounds.
引用
收藏
页码:2091 / 2092
页数:2
相关论文
共 50 条
  • [21] Treat Obesity to Treat Type 2 Diabetes Mellitus
    Sulu, Cem
    Yumuk, Volkan Demirhan
    DIABETES THERAPY, 2024, 15 (03) : 611 - 622
  • [22] LEPTIN LEVELS IN TYPE 2 DIABETES MELLITUS AND OBESITY
    Kural, Alev
    Aslan, Berna
    Eren, Nezaket
    Cigerli, Sebnem
    Koldas, Macit
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2007, 45 (03): : 162 - 168
  • [23] Management of Obesity in Patients with Type 2 Diabetes Mellitus
    Gagliardi, Lucia
    Witterti, Gary
    CURRENT DIABETES REVIEWS, 2007, 3 (02) : 95 - 101
  • [24] Isoglucose, the risk of obesity and type 2 diabetes mellitus
    Broz, Jan
    LISTY CUKROVARNICKE A REPARSKE, 2017, 133 (9-10): : 325 - 325
  • [25] Treat Obesity to Treat Type 2 Diabetes Mellitus
    Cem Sulu
    Volkan Demirhan Yumuk
    Diabetes Therapy, 2024, 15 : 611 - 622
  • [26] Genetics of type 2 diabetes mellitus and obesity - a review
    Jafar-Mohammadi, Bahram
    Mccarthy, Mark I.
    ANNALS OF MEDICINE, 2008, 40 (01) : 2 - 10
  • [27] The Evidence for an Obesity Paradox in Type 2 Diabetes Mellitus
    Han, Seung Jin
    Boyko, Edward J.
    DIABETES & METABOLISM JOURNAL, 2018, 42 (03) : 179 - 187
  • [28] Obesity and Vascular Events in Type 2 Diabetes Mellitus
    Millan Longo, Claudia
    Garcia Montero, Marta
    Tebar Marquez, Daniel
    Beltran Romero, Luis
    Banegas, Jose R.
    Garcia Puig, Juan
    REVISTA ESPANOLA DE CARDIOLOGIA, 2015, 68 (02): : 151 - 153
  • [29] Understanding the Obesity Paradox in Type 2 Diabetes Mellitus
    Costanzo P.
    Lai D.
    Atkin S.L.
    Current Cardiovascular Risk Reports, 2015, 9 (7)
  • [30] Obesity and type 2 diabetes mellitus: A treatment challenge
    Gumbiner, B
    Battiwalla, M
    ENDOCRINOLOGIST, 2002, 12 (01): : 23 - 28